Publications by authors named "G Neri Cini"

(1) Background: hypermethylation is an epigenetic alteration in the tumorigenesis of colorectal cancer (CRC) and endometrial cancer (EC), causing gene silencing, and, as a consequence, microsatellite instability. Commonly, hypermethylation is considered a somatic and sporadic event in cancer, and its detection is recognized as a useful tool to distinguish sporadic from inherited conditions (such as, Lynch syndrome (LS)). However, hypermethylation has been described in rare cases of CRC and EC in LS patients.

View Article and Find Full Text PDF

This study aims to investigate the sensitivity of microscopy, culture and polymerase chain reaction on three gastric aspirates (GAs) in the microbiological confirmation of active pulmonary tuberculosis (TB) and to identify possible changes in sensitivity derived from the collection of a different number of aspirates. Children with clinical and radiological diagnoses of active pulmonary TB who underwent three GAs between March 2007 and June 2019 were retrospectively evaluated. Clinical, radiological, and microbiological data were collected.

View Article and Find Full Text PDF

Backgrounds: MUTYH-associated polyposis (MAP) is an autosomal recessive disease caused by biallelic pathogenic variants (PV) of the MUTYH gene. The aim of this study was to investigate the genetic causes of unexplained polyposis patients with monoallelic MUTYH PV. The analysis focused on 26 patients with suspected MAP, belonging to 23 families.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers studied the impact of new polygenic risk scores (PRS) for breast and prostate cancer on male carriers of BRCA1 and BRCA2 gene mutations, analyzing data from 1,801 individuals across these two genes.
  • The breast cancer PRS showed the strongest link to risk factors for BRCA1 and BRCA2 carriers, with specific odds ratios indicating increased risk associated with certain risk score variations.
  • The findings highlight the need for further research to tailor cancer risk assessments for male BRCA mutation carriers, which could improve their clinical management and outcomes.
View Article and Find Full Text PDF